Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DUAL-TARGET STAR TARGETING CD19 AND CD22
Document Type and Number:
WIPO Patent Application WO/2022/179545
Kind Code:
A1
Abstract:
The present invention relates to the field of biological medicine, and in particular relates to a dual-target synthetic T-cell receptor and antigen receptor (STAR), and the use thereof. Specifically, disclosed in the present invention are a dual-target STAR targeting CD19 and CD22, a T cell containing the dual-target STAR and the uses thereof.

Inventors:
RUI WEI (CN)
LEI LEI (CN)
WU CHUNYAN (CN)
LIU FANG (CN)
Application Number:
PCT/CN2022/077608
Publication Date:
September 01, 2022
Filing Date:
February 24, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHINA IMMUNOTECH BEIJING BIOTECHNOLOGY CO LTD (CN)
International Classes:
C07K19/00; A61K35/17; A61K39/00; A61P35/00; A61P35/02; C07K14/725; C07K16/30; C12N5/10; C12N15/62
Foreign References:
CN110741016A2020-01-31
CN110177803A2019-08-27
CN111499767A2020-08-07
CN110964122A2020-04-07
CN111320703A2020-06-23
CN110352068A2019-10-18
CN111886243A2020-11-03
US20190359678A12019-11-28
CN110545883A2019-12-06
Other References:
LEWIN, GENES VIII
ROITT ET AL.: "Immunology"
Attorney, Agent or Firm:
NTD UNIVATION INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: